The Scientific and Research Team at GARDP spearheads the development of new antibiotic treatments for drug-resistant bacterial infections. This team is responsible for the discovery, exploratory research, and project management of R&D initiatives. They work closely with global partners to advance scientific knowledge, manage R&D portfolios, and ensure the safe and effective development of new treatments aligned with public health needs. Their efforts are critical for addressing the antimicrobial resistance crisis and securing essential antibiotics for future generations.
View all